HomeProductsBuilding BlocksHeterocyclic ScaffoldsTetrahydropyransErythromycin Estolate
Chemical structure of CAS 3521-62-8

Erythromycin Estolate

In Stock•Starting at $9 for 5 mg•Purity ≥ 98%
CAS No.3521-62-8
MDL No.MFCD00084691
MFC52H97NO18S
MW1056.40
InChI KeyAWMFUEJKWXESNL-JZBHMOKNSA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
5 mgTo Be Confirmed$9In Stock
25 mgTo Be Confirmed$9In Stock
5 g98%$10In Stock
25 gTo Be Confirmed$14In Stock
100 gTo Be Confirmed$50In Stock
Custom synthesis and bulk supply options are available upon request.

Product Information

Erythromycin estolate is an erythromycin derivative and aminoglycoside sulfate salt. It functions as an enzyme inhibitor and contains erythromycin A 2'-propanoate.

CAS No.3521-62-8
Product NameErythromycin Estolate
IrritantIrritant
Health HazardHealth Hazard
Signal Word:Danger
HCode:H302-H317-H334
PCode:P233-P260-P261-P264-P270-P271-P272-P280-P284-P301+P317-P302+P352-P304+P340-P321-P330-P333+P317-P342+P316-P362+P364-P403-P501

Related Articles

Studies related to this compound and its mechanism of action

Evaluating the Role of Multidrug Resistance Protein 3 (MDR3) Inhibition in Predicting Drug-Induced Liver Injury Using 125 Pharmaceuticals.

Chemical research in toxicology • Vol. 30, Issue 5 • 2017
PMID: 28437613DOI: 10.1021/acs.chemrestox.7b00048

Integrated systems toxicology approaches identified the possible involvement of ABC transporters pathway in erythromycin estolate-induced liver injury in rat.

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association • Vol. 65 • 2014
PMID: 24412560DOI: 10.1016/j.fct.2013.12.050

A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.

Toxicological sciences : an official journal of the Society of Toxicology • Vol. 136, Issue 1 • 2013
PMID: 23956101DOI: 10.1093/toxsci/kft176

Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.

Toxicological sciences : an official journal of the Society of Toxicology • Vol. 118, Issue 2 • 2010
PMID: 20829430DOI: 10.1093/toxsci/kfq269

Documentation

Similar Products